Elaine R. Mardis, Ph.D.,  The Genome Institute

Dr. Mardis joined the Genome Institute in 1993. As Director of Technology Development she has helped create methods and automation pipelines for sequencing the human genome. She currently orchestrates the institute's efforts to explore next generation and third generation sequencing technologies and transition them into production sequencing capabilities.

Dr. Mardis has research interests in the application of DNA sequencing to characterize cancer genomes. She also is interested in facilitating the translation of basic science discoveries about human disease into the clinical setting.

Dr. Mardis serves on several NIH study sections, is an editorial board member of Genome Research and acts as a reviewer for Nature *and *Genome Research. She serves as chair of the Basic and Translational Sciences Committee for the American College of Surgeons Oncology Group, a National Cancer Institute-funded cooperative group. She serves on the scientific advisory boards of Pacific Biosciences, Inc. and Edge Biosciences, Inc. In 2010 Dr. Mardis received the Scripps Translational Research award for her work on cancer genomics and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences for 2011.

Dr. Mardis is also Professor in the Department of Genetics, with an adjunct appointment in the Department of Molecular Microbiology. Prior to joining the Washington University faculty, she was a senior research scientist at Bio-Rad Laboratories in Hercules, CA. Dr. Mardis received her B.S. degree (Zoology with Highest Honors, 1984) and her Ph.D. (Chemistry and Biochemistry, 1989) from the University of Oklahoma.

Publications